Health ❯ Healthcare ❯ Chronic Conditions

Type 2 Diabetes

Management Strategies Weight Management Medication Management GLP-1 Medications Weight Loss Medications Treatment Options GLP-1 Drug Usage Medication Treatments Insulin Sensitivity Obesity Management Diabetes Management GLP-1 Drugs Hypertension Obesity and Diabetes Management and Treatment GLP-1 Agonists Atherosclerotic Cardiovascular Disease Obesity CagriSema Treatment Medication Usage GLP-1 Hormones Semaglutide Use Medication Access GLP-1 Receptor Agonists Monitoring and Management

Vanderbilt Study Maps 70 Conditions That Precede Alzheimer’s by a Decade

The findings offer a data-driven starting point for earlier risk recognition without establishing cause.

Novo Nordisk Files FDA Application for Weekly CagriSema Obesity Shot as GLP-1 Competition Intensifies

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies